| LINE ITEM (USD / %) | FY 2025
FILED 2025-09-30 | FY 2024
FILED 2024-09-30 | FY 2023
FILED 2023-09-30 |
|---|---|---|---|
| Revenue (Total Sales) | $251.8M | $331.5M | $294.5M |
| YoY Revenue Growth % | -24.0% | +12.6% | — |
| Gross Profit | $183.1M | $244.3M | — |
| Gross Margin % | 72.7% | 73.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$2.3M | -$579.9M | -$27.2M |
| Operating Margin % | -0.9% | -80.0% | -9.2% |
| Net Income (GAAP) | -$18.7M | -$588.1M | -$56.3M |
| EBITDA (Normalized) | $9.2M | -$575.9M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $61.2M | $17.2M | $7.5M |
| Capital Expenditures (CapEx) | $14.4M | $5.0M | — |
| Free Cash Flow (FCF) | $46.8M | $12.2M | $7.5M |
| FCF Margin % | 18.6% | 3.7% | 2.5% |
| Return on Invested Capital (ROIC %) | -0.6% | -45.0% | — |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $171.9M | $196.2M | — |
| Total Stockholders' Equity | $150.4M | $120.7M | — |